Using Viruses to Boost Mesothelioma Immunotherapy

Immunotherapy through clinical trials is becoming a promising treatment option for some mesothelioma patients. Checkpoint inhibitor drugs, such as Keytruda, already have U.S. Food and Drug Administration (FDA) approval as first-line treatments for non-small cell lung cancer (NSCLC), edging immunotherapy drugs closer to becoming a viable second-line therapy for other thoracic cancers, including pleural mesothelioma. However, overall response to immune therapies remains relatively low. Researchers across the country are striving to enhance responsiveness to immunotherapy drugs. Leading that trend is viroimmunotherapy, or the process of combining cancer-killing (oncolytic) viruses with immunotherapy drugs. Dr. Manish Patel, an assistant professor in the division of hematology, oncology and transplantation at the University of Minnesota, has studied the potential of virus therapy for mesothelioma for several years. His research led to an ongoing clinical trial at the Mayo Clinic in Rochester, Minnesota, investigating the side effects and optimal dosage levels of using a genetically altered measles virus to kill mesothelioma tumor cells. Patel and Dr. Alexander Dash of Macalester College in St. Paul, Minnesota, recently published a paper in the journal Biomedicines that analyzes measles and other oncolytic viruses as potential viroimmunotherapy treatments for pleural mesothelioma and other thoracic cancers. As research continues, Patel believes the day of using viruses to in...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Biomedicines checkpoint blockade Checkpoint inhibitor drugs clinical trials for mesothelioma Dr. Alexander Dash Dr. Manish Patel FDA approval Keytruda immune response cancer immunotherapy response mesothelioma intratumoral injections k Source Type: news

Related Links:

[Daily News] MEDICAL experts in the country have raised considerable concern over raising cases of retinoblastoma, an eye cancer that develops in early childhood.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[Nairobi News] It was tears of joy and high-fives at Kijabe Hospital on Wednesday as a young girl excitedly marked the end of her cancer treatment by ringing a bell.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Objective: Although the prognostic significance of systematic inflammation-based scores, such as the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), and the prognostic nutritional index (PNI), have been explored in pancreatic cancers, few reports have investigated the lymphocyte-to-monocyte ratio (LMR). We aimed to retrospectively investigate the prognostic value of the preoperative LMR in patients with resectable pancreatic head cancer (PHC). Methods: From 2005 to 2016, 165 patients underwent pancreatoduodenectomy for PHC. All samples of peripheral blood were collected within two weeks prior ...
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research
(Wiley) Results from a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, point to the need for improved access to medical care for sexual minority cancer survivors, in particular female survivors.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The American Society of Clinical Oncology's 20-year study looked at 49,000 women split into two groups with varying diets
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
NEW developments in the world of science and disease prevention are constantly evolving. The power, speed and accuracy of AI could be a game changer. So are we in the midst of the greatest discoveries for the medical world? New research has shown how AI has helped in the detection of lung cancer.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
We present a case of a 19-month infant who was taken to the Emergency Department due to fever and a gingival lesion that did not respond to antibiotic treatment. An ultrasound study was requested to assess the presence of an abscess. However, a lesion was identified and after performing a biopsy, pathologist found it was a myeloid sarcoma. The patient was diagnosed with AML and chemotherapy treatment was started. After three cycles of treatment, the patient is currently free of disease.
Source: Revista Espanola de Cirugia Oral y Maxilofacial - Category: ENT & OMF Source Type: research
We present a case of a 19-month infant who was taken to the Emergency Department due to fever and a gingival lesion that did not respond to antibiotic treatment. An ultrasound study was requested to assess the presence of an abscess. However, a lesion was identified and after performing a biopsy, pathologist found it was a myeloid sarcoma. The patient was diagnosed with AML and chemotherapy treatment was started. After three cycles of treatment, the patient is currently free of disease.
Source: Revista Espanola de Cirugia Oral y Maxilofacial - Category: ENT & OMF Source Type: research
ConclusionAdvances have been more prominent in cases of auditory neuropathy, since partial improvement of auditory nerve conditions through cell-based therapy may increase the number of patients who can successfully receive cochlear implants.ResumoIntroduçãoCélulas ciliadas de mamíferos e neurônios auditivos não apresentam capacidade regenerativa. Assim, os danos a esses tipos de células são permanentes, levam à perda auditiva, e não há tratamento que restabeleça a função auditiva. Terapias regenerativas utilizando célul...
Source: Brazilian Journal of Otorhinolaryngology - Category: ENT & OMF Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Environmental Health | Food and Drug Administration (FDA) | Genetics | Hematology | Immunotherapy | Lung Cancer | Lung Transplant | Measles | Measles Vaccine | Melanoma | Mesothelioma | Non-Small Cell Lung Cancer | Skin Cancer | Study | Transplants | University of Minnesota | Vaccines | Veterinary Vaccinations | Virotherapy